$12.9M Awarded In 3 New Jersey Accutane IBD Cases
ATLANTIC CITY, N.J. - A New Jersey state court jury on Oct. 19 awarded $12,895,500 to three plaintiffs who claim that their inflammatory bowel disease (IBD) was caused by Hoffman-La Roche Inc.’s acne drug Accutane (Kelly Mace v. Hoffman-La Roche Inc., et al., No. ATL-L-199-05 MT, Jordan Speisman v. Hoffman-La Roche Inc., et al., No. ATL-L-196–05 MT, Lance Sager v. Hoffman-La Roche Inc., et al., No. ATL-L-197-05 MT, N.J. Super., Atlantic Co.).
Full story on lexis.com
Original post by LexisNexis® Mealey’sâ„¢ Legal News